{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:36:10Z","timestamp":1792416970502,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014848","name":"Arnold Ventures LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1U01DA050442"],"award-info":[{"award-number":["1U01DA050442"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA043487"],"award-info":[{"award-number":["R21DA043487"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007292"],"award-info":[{"award-number":["T32DA007292"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009827","name":"Laura and John Arnold Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jsat.2021.108690","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T01:59:36Z","timestamp":1639360776000},"page":"108690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Treatment preference for opioid use disorder among people who are incarcerated"],"prefix":"10.1016","volume":"137","author":[{"given":"Eliana","family":"Kaplowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley Q.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Wieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Brinkley-Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jsat.2021.108690_bb0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108690_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.016","article-title":"The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting","volume":"205","author":"Brinkley-Rubinstein","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108690_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10","key":"10.1016\/j.jsat.2021.108690_bb0025","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2105\/AJPH.2018.304666","article-title":"The first comprehensive program for opioid use disorder in a US statewide correctional system","volume":"108","author":"Clarke","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108690_bb0030","series-title":"National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","volume":"66","author":"Comer","year":"2015"},{"issue":"12","key":"10.1016\/j.jsat.2021.108690_bb7000","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2021.108690_bb0050","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1360-0443.2004.00772.x","article-title":"The effect of matching comprehensive services to patients\u2019 needs on drug use improvement in addiction treatment","volume":"99","author":"Friedmann","year":"2004","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"10.1016\/j.jsat.2021.108690_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145817","article-title":"Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature","volume":"11","author":"Friedrichs","year":"2016","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of Racial\/Ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2021.108690_bb0070","first-page":"285","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban equal access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions\/American Academy of Psychiatrists in Alcoholism and Addictions"},{"key":"10.1016\/j.jsat.2021.108690_bb0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2017.08.019","article-title":"The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use","volume":"180","author":"Huhn","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.jsat.2021.108690_bb9000","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000219524","article-title":"Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients","volume":"78","author":"Joosten","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"3","key":"10.1016\/j.jsat.2021.108690_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2021.108690_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1192\/pb.28.2.47","article-title":"Treatment preferences of opiate-dependent patients","volume":"28","author":"Luty","year":"2004","journal-title":"Psychiatric Bulletin"},{"key":"10.1016\/j.jsat.2021.108690_bb8000","doi-asserted-by":"crossref","first-page":"105766","DOI":"10.1016\/j.ypmed.2019.105766","article-title":"Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program","volume":"128","author":"Martin","year":"2019","journal-title":"Preventive Medicine"},{"issue":"9","key":"10.1016\/j.jsat.2021.108690_bb0100","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.jsat.2021.108690_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsat.2019.08.006","article-title":"Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results","volume":"108","author":"Mooney","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108690_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","article-title":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support","volume":"100","author":"Muthulingam","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108690_bb0115","series-title":"Medications for opioid use disorder save lives","year":"2019"},{"key":"10.1016\/j.jsat.2021.108690_bb0125","series-title":"Criminal justice DrugFacts","year":"2020"},{"key":"10.1016\/j.jsat.2021.108690_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108214","article-title":"Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19","volume":"122","author":"Nguemeni Tiako","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjms.2016.05.020","article-title":"Infectious diseases and the criminal justice system: A public health perspective","volume":"352","author":"Nijhawan","year":"2016","journal-title":"The American Journal of the Medical Sciences"},{"issue":"35","key":"10.1016\/j.jsat.2021.108690_bb0140","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital signs: Characteristics of drug overdose deaths involving opioids and Stimulants\u201424 states and the District of Columbia, January\u2013June 2019","volume":"69","author":"O\u2019Donnell","year":"2020","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40429-019-00283-x","article-title":"Medications for opioid use disorder among incarcerated individuals: A review of the literature and focus on patient preference","volume":"6","author":"Puglisi","year":"2019","journal-title":"Current Addiction Reports"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000584","article-title":"Comparing reasons for starting and stopping methadone, buprenorphine, and naltrexone treatment among a sample of white individuals with opioid use disorder","volume":"14","author":"Randall-Kosich","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"9991","key":"10.1016\/j.jsat.2021.108690_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.jsat.2021.108690_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jclp.20553","article-title":"The impact of client treatment preferences on outcome: A meta-analysis","volume":"65","author":"Swift","year":"2009","journal-title":"Journal of Clinical Psychology"},{"issue":"5","key":"10.1016\/j.jsat.2021.108690_bb0175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02791072.2014.921743","article-title":"Patient perspectives on buprenorphine\/naloxone: A qualitative study of retention during the starting treatment with agonist replacement therapies (START) study","volume":"46","author":"Teruya","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.jsat.2021.108690_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1098214005283748","article-title":"A general inductive approach for analyzing qualitative evaluation data","volume":"27","author":"Thomas","year":"2006","journal-title":"American Journal of Evaluation"},{"key":"10.1016\/j.jsat.2021.108690_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients\u2019 beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221004165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221004165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:28:32Z","timestamp":1778693312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221004165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"alternative-id":["S0740547221004165"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108690","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment preference for opioid use disorder among people who are incarcerated","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108690"}}